| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 231.63M | 221.16M | 252.99M | 278.76M | 371.28M | 224.59M |
| Gross Profit | 25.75M | 180.10M | 196.55M | 255.08M | 344.26M | 195.77M |
| EBITDA | 19.99M | 9.18M | -118.30M | 46.89M | 163.91M | 71.13M |
| Net Income | -109.22M | -20.49M | -156.81M | -87.84M | 134.07M | 100.55M |
Balance Sheet | ||||||
| Total Assets | 277.24M | 445.83M | 451.04M | 593.95M | 709.15M | 681.12M |
| Cash, Cash Equivalents and Short-Term Investments | 29.88M | 60.73M | 56.56M | 37.03M | 52.13M | 20.38M |
| Total Debt | 28.54M | 44.93M | 67.38M | 78.25M | 116.29M | 209.30M |
| Total Liabilities | 62.73M | 130.45M | 162.06M | 145.68M | 192.77M | 298.83M |
| Stockholders Equity | 215.08M | 316.14M | 289.62M | 448.61M | 516.83M | 382.71M |
Cash Flow | ||||||
| Free Cash Flow | -20.88M | -19.26M | 15.57M | 17.29M | 151.89M | 58.16M |
| Operating Cash Flow | -609.00K | -1.91M | 55.26M | 31.74M | 165.10M | 63.97M |
| Investing Cash Flow | -21.48M | -15.88M | -15.06M | -14.12M | -13.75M | -1.08M |
| Financing Cash Flow | 3.86M | 16.14M | -19.25M | -30.54M | -119.90M | -45.47M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
70 Outperform | HK$55.10B | 54.44 | 36.46% | 1.32% | 31.24% | 58.16% | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% | |
51 Neutral | HK$490.60M | -1.44 | -41.19% | ― | -6.51% | 41.00% | |
44 Neutral | HK$2.25B | -3.90 | -14.35% | ― | -31.35% | -71.37% | |
41 Neutral | HK$702.87M | -0.81 | -44.33% | ― | 2.05% | 27.51% | |
41 Neutral | HK$825.94M | -24.05 | -7.49% | ― | ― | -164.29% | |
41 Neutral | HK$1.14B | -3.58 | -4702.63% | ― | 0.41% | 83.35% |
IRC Limited, a Hong Kong‑incorporated company listed on the Stock Exchange of Hong Kong, is conducting a rights issue of new shares to existing shareholders on the basis of one rights share for every two existing shares held on the record date, on a non‑fully underwritten basis. Under its ongoing rights issue, IRC received valid applications for approximately 73% of the 638.97 million rights shares on offer, with the underwriter taking up the bulk under an irrevocable undertaking; the remaining roughly 27% unsubscribed shares will be placed to independent investors under compensatory arrangements, with any net premium over subscription and placing costs distributed pro rata to eligible non‑participating shareholders above a HK$100 threshold, while any rights shares still left unsold will simply not be issued, reducing the final size of the capital raising.
The most recent analyst rating on (HK:1029) stock is a Hold with a HK$0.48 price target. To see the full list of analyst forecasts on IRC stock, see the HK:1029 Stock Forecast page.
IRC Limited, a company incorporated in Hong Kong, announced the successful passage of a resolution at its Extraordinary General Meeting (EGM) held on December 16, 2025. The resolution, which was approved by the independent shareholders, pertains to a Rights Issue and related agreements, which are set to proceed according to the previously outlined timetable. This development indicates a strategic move by IRC to potentially raise capital and strengthen its financial position, with significant implications for its stakeholders and market operations.
The most recent analyst rating on (HK:1029) stock is a Hold with a HK$0.50 price target. To see the full list of analyst forecasts on IRC stock, see the HK:1029 Stock Forecast page.
IRC Limited, a company incorporated in Hong Kong, has announced an Extraordinary General Meeting (EGM) to be held on December 16, 2025. The meeting will consider a proposed rights issue, which involves issuing new ordinary shares to existing shareholders. This initiative is part of a broader strategy to raise capital, with the involvement of Axioma Capital FZE LLC as the underwriter and First Shanghai Securities Limited as the placing agent. The rights issue aims to strengthen the company’s financial position and enhance its market presence.
The most recent analyst rating on (HK:1029) stock is a Hold with a HK$0.50 price target. To see the full list of analyst forecasts on IRC stock, see the HK:1029 Stock Forecast page.